ADVERTISEMENT
JB Chemicals' Acquisition Strategically Positive For Torrent Pharma, Says Motilal Oswal — Maintains 'Neutral'
While the deal is positive, Motilal Oswal reiterates its Neutral rating on the stock due to limited upside from the current levels.
30 Jun 2025, 03:38 PM IST 
Save
Torrent Pharmaceuticals Ltd. is set to acquire a controlling stake in JB Chemicals and Pharmaceuticals, the deal is at an equity valuation of Rs 256 billion
(Photo by Myriam Zilles on Unsplash)
With this acquisition, Torrent Pharma would have access to a fast-growing domestic formulation business with a healthy share of the chronic portfolio. In addition, Torrent Pharma would garner the international contract development manufacturing organisation business of JB Chemicals.
